Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
2011-08-02
2011-08-02
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
C548S503000
Reexamination Certificate
active
07989494
ABSTRACT:
Polymorphic forms of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide free base and salts thereof are prepared by various processes.
REFERENCES:
patent: 2009/1297936 (2009-08-01), Acemoglu
patent: 2010/0286409 (2010-11-01), Acemoglu
patent: WO-02/22577 (2002-03-01), None
patent: WO 03/039599 (2003-05-01), None
patent: WO 03/048774 (2003-06-01), None
patent: WO 2004/103358 (2004-02-01), None
patent: 2005/013958 (2005-02-01), None
patent: 2005/027972 (2010-03-01), None
Giles, et al., Clin. Cancer Res. 12:4628 (2006).
Ellis, et al., Clin. Cancer Res., 14:4500 (2008).
Rathkopf, et al., J. Clin. Oncol. 26:abstr# 5152 (2008).
Duvic, et al., J. Clin. Oncol., 26:abstr 8555 (2008).
Tan et al., J. Hematology & Oncology, 3:5 (2010).
Schafer et al. Drug Discovery Today, 13:913 (2008).
Horig et al. Journal of Translational Medicine, 2:44 (2004).
Soghoian Samara et al: “Toxicity, heavy metals”, eMedicine from WebMD (15 pages) accessed online Dec. 28, 2009.
Bastin Richard J et al: “Salt selection and optimisation procedures for pharmaceutical new chemical entities”, Organic Process Research & Development, 2000, vol. 4, pp. 427-435.
Alfa Aesar catalog, Lactic acid entry, accessed online Dec. 29, 2009.
Chemindustry.com entry for “EINECS No. 200-018-0” accessed online Dec. 20, 2009.
Stacy W. Remiszewski, S.W. et al., “N-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity: Discovery of (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]-phenyl]-2-propenamide (NVP-LAQ824)” Journal of Medicinal Chemistry, US American Chemical Society, Washington, vol. 46, Jan. 1, 2003 pp. 4609-4624.
International Search Report by Austrian Patent Office for Singapore application No. 200808629-0, (Aug. 6, 2010).
U.S. Appl. No. 12/302,571 Office Action dated Oct. 9, 2009.
U.S. Appl. No. 12/302,571 Office Action dated Jan. 7, 2010.
U.S. Appl. No. 12/775,001 Office Action dated Sep. 17, 2010.
Acemoglu Murat
Bajwa Joginder S.
Karpinski Piotr
Papoutsakis Dimitris
Slade Joel
Barker Michael
Mulkeen Matthew
Novartis AG
Saeed Kamal
LandOfFree
Polymorphs of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphs of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphs of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2750099